Literature DB >> 22418892

Testing for cervical cancer: new recommendations from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology.

.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22418892     DOI: 10.3322/caac.21135

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  5 in total

1.  FOXA1-induced circOSBPL10 potentiates cervical cancer cell proliferation and migration through miR-1179/UBE2Q1 axis.

Authors:  Shanshan Yang; Yiwen Jiang; Xiaoli Ren; Dan Feng; Liaoyun Zhang; Deying He; Shiyao Hong; Li Jin; Fang Zhang; Shun Lu
Journal:  Cancer Cell Int       Date:  2020-08-12       Impact factor: 5.722

2.  Long noncoding RNA GIHCG functions as an oncogene and serves as a serum diagnostic biomarker for cervical cancer.

Authors:  Xiaolian Zhang; Lihua Mao; Lihua Li; Zhihong He; Naiqun Wang; Yanfeng Song
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

3.  LINC00885 promotes cervical cancer progression through sponging miR-3150b-3p and upregulating BAZ2A.

Authors:  Yeling Liu; Jingrui Chen; Lizhong Zhou; Chunhua Yin
Journal:  Biol Direct       Date:  2022-01-10       Impact factor: 4.540

4.  Individual and community-level determinants of cervical cancer screening in Zimbabwe: a multi-level analyses of a nationwide survey.

Authors:  Alone Isabirye; Bob Charlestine Elwange; Kavita Singh; Manuela De Allegri
Journal:  BMC Womens Health       Date:  2022-07-25       Impact factor: 2.742

5.  Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.

Authors:  Yujuan Zhang; Donghong Zhang; Fei Wang; Danfei Xu; Ye Guo; Wei Cui
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.